Literature DB >> 9253653

Myelin proteolipid DM20: evidence for function independent of myelination.

N L Nadon1, S Miller, K Draeger, M Salvaggio.   

Abstract

DM20 is a proteolipid protein that has been extensively studied for its role in central nervous system myelination. We demonstrate that DM20 expression is widespread and independent of myelination. In the Schwann cells and neurons of the peripheral nervous system, DM20 is not incorporated into the membrane as it is in the central nervous system (CNS), but remains cytoplasmic. Mutations that severely reduce the amount of DM20 mRNA in CNS myelinating cells have little effect on DM20 expression in nonmyelinating cells of the peripheral nervous system and embryonic CNS. Most importantly, the combination of wild-type DM20 from the endogenous X-linked gene and mutant DM20 expressed from an autosomal transgene results in embryonic lethality. We propose a function for DM20 to explain these diverse findings based on the ability of DM20 to form multimeric complexes, and hypothesize that the DM20 complex participates in intracellular molecular transport.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9253653     DOI: 10.1016/s0736-5748(97)00009-9

Source DB:  PubMed          Journal:  Int J Dev Neurosci        ISSN: 0736-5748            Impact factor:   2.457


  8 in total

1.  Myelin proteolipid protein-induced aggregation of lipid vesicles: efficacy of the various molecular species.

Authors:  Oscar A Bizzozero; Tamara A Howard
Journal:  Neurochem Res       Date:  2002-11       Impact factor: 3.996

2.  Insertion of proteolipid protein into mitochondria but not DM20 regulates metabolism of cells.

Authors:  Mallika Somayajulu; Denise A Bessert; Maik Hüttemann; Jasloveleen Sohi; John Kamholz; Robert P Skoff
Journal:  Neurosci Lett       Date:  2018-05-02       Impact factor: 3.046

3.  Membrane glycoprotein M6B interacts with the human serotonin transporter.

Authors:  Anja Winther Fjorback; Heidi Kaastrup Müller; Ove Wiborg
Journal:  J Mol Neurosci       Date:  2008-06-26       Impact factor: 3.444

4.  PMD patient mutations reveal a long-distance intronic interaction that regulates PLP1/DM20 alternative splicing.

Authors:  Jennifer R Taube; Karen Sperle; Linda Banser; Pavel Seeman; Barbra Charina V Cavan; James Y Garbern; Grace M Hobson
Journal:  Hum Mol Genet       Date:  2014-06-01       Impact factor: 6.150

5.  Identification of GPM6A and GPM6B as potential new human lymphoid leukemia-associated oncogenes.

Authors:  Cyndia Charfi; Elsy Edouard; Eric Rassart
Journal:  Cell Oncol (Dordr)       Date:  2014-06-12       Impact factor: 6.730

6.  The proteolipid protein promoter drives expression outside of the oligodendrocyte lineage during embryonic and early postnatal development.

Authors:  John-Paul Michalski; Carrie Anderson; Ariane Beauvais; Yves De Repentigny; Rashmi Kothary
Journal:  PLoS One       Date:  2011-05-10       Impact factor: 3.240

7.  Embryonic expression of the soma-restricted products of the myelin proteolipid gene in motor neurons and muscle.

Authors:  Erin C Jacobs; Ernesto R Bongarzone; Celia W Campagnoni; Anthony T Campagnoni
Journal:  Neurochem Res       Date:  2004-05       Impact factor: 3.996

8.  Breast carcinoma progression and tumour vascular markers related to apoptotic mechanisms.

Authors:  Miroslava Bilecova-Rabajdova; Peter Urban; Kristina Gregova; Jan Varga; Viera Fialkovicová; Peter Kruzliak; Maria Marekova
Journal:  Dis Markers       Date:  2014-02-18       Impact factor: 3.434

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.